Brellium Raises $16.7 Million to Build Healthcare's AI-Powered Clinical Compliance Platform

Healthcare compliance is undergoing a seismic shift. For decades, organizations have relied on manual chart audits that cover a mere 5-10% of clinical documentation. This sampling approach was born of necessity — reviewing every chart by hand is simply impossible at scale. But the consequences of this gap are staggering: missed coding errors, undetected compliance violations, and revenue lost to clawbacks that could have been prevented.

The Problem with Sampling

When you audit only a fraction of charts, you are making a bet that the sample is representative. But clinical documentation is inherently variable. Different providers, different patients, different conditions — each introduces unique compliance risks that a random sample may miss entirely. The result is a false sense of security that can be shattered by a single payor audit.

The AI-Powered Alternative

AI-powered chart auditing changes the equation entirely. By analyzing every chart against your specific compliance requirements in real time, you eliminate the risk of sampling bias. Every patient encounter is reviewed, every coding decision is validated, and every documentation gap is flagged before it becomes a liability. This is not incremental improvement — it is a fundamental transformation in how healthcare organizations approach compliance.

Brellium exists because a simple documentation oversight nearly derailed my care.

A few years before co-founding Brellium, I was misdiagnosed. What should have been a straightforward course of care turned into two years of frustration: bouncing between specialists, trying treatment after treatment, racking up bills, and spending countless hours on the phone with insurance. Eventually, I learned that most of this could have been avoided if a few basic items had been properly documented in my chart.

That experience made something painfully clear: the system wasn’t just failing me as a patient—it was also failing providers, who lacked the tools to consistently deliver accurate, compliant, measurement-based care. Brellium was born from that realization.

The Hidden Cost of Chart Reviews

Every time you receive care, your provider documents the visit to meet both clinical and payor requirements. This documentation is what ensures:

• Your care is clinically appropriate and safe
• Insurance will reimburse the services provided

When documentation falls short, the consequences for provider groups are severe:

• Financial risk: Missed or unclear payor requirements can trigger prepayment reviews, insurance clawbacks, and serious cash-flow instability. Clinics may be forced to repay funds that have already gone toward salaries, operations, and patient care.
• Clinical risk: Documentation gaps can lead to misdiagnoses, incomplete treatment plans, and worse patient outcomes.

Chart reviews are supposed to be the safety net that catches these issues—but the way they’re done today simply doesn’t work.

Manual Chart Reviews: A Lose-Lose

Most clinics don’t have the capacity to review every chart. Instead, they manually spot-check a small fraction of visits, hoping to catch critical errors before they become costly problems.

This approach is broken:

• Labor-intensive: Manual reviews require highly trained clinicians and QA staff, pulling them away from patient care.
• Error-prone: Humans get tired, rushed, and inconsistent—especially at scale.
• Not scalable: As patient volume grows, QA capacity rarely keeps pace.

Clinics are forced into an impossible tradeoff: prioritize compliance and drown in administrative work, or prioritize efficiency and accept higher risk.

To make matters worse, payor requirements are often opaque and inconsistent. In one recent audit of Medicaid-funded ABA therapy in Indiana, every sampled month contained improper or potentially improper payments—mostly due to inadequate documentation. Provider groups are left to interpret vague rules, with limited guidance and high stakes.

The system needs a better way to ensure compliance and quality—one that scales with modern healthcare.

Brellium: The AI-Powered Clinical Compliance Platform

Brellium gives clinical teams a way to ensure that every patient visit meets payor and clinical quality standards—without the crushing manual workload.

Instead of reactive spot-checks, Brellium:

• Proactively audits 100% of visits for documentation and clinical quality issues
• Surfaces compliance risks in real time, before they turn into clawbacks or patient harm
• Notifies providers instantly when a chart needs correction, with clear, actionable guidance on how to fix it

And we stand behind our work: if a payor claws back reimbursement on a Brellium-approved chart, we’ll foot the bill.

With Brellium, providers can automatically detect and correct issues such as:

• Copy-pasted notes from prior sessions
• Contraindicated medications
• Mismatches between documented session length and what was billed
• Worsening patient condition over time that isn’t addressed in the plan of care
• …and hundreds of other clinical and compliance risk patterns

Leading healthcare organizations—including Grow Therapy, Rula, Headspace, Hopebridge, Lightfully Behavioral Health, Talkiatry, and others—use Brellium to streamline compliance across millions of patient visits. We’ve already audited millions of charts, giving organizations deep visibility into how payors interpret and enforce documentation standards in the real world.

The impact is tangible:

• Rula is using clinical note data to actively improve quality of care.
• Lightfully Behavioral Health reduced time spent on chart auditing by 87%.
• DoubleCare ABA cut QA costs by over 80%.

By eliminating inefficiencies and reducing administrative burden, Brellium helps clinics focus on what matters most: delivering better care to patients.

Raising the Standard of Care in the U.S.

What started as a personal frustration has grown into a mission-driven company backed by an incredible group of partners.

We’ve raised $16.7 million in Series A funding from:

• First Round Capital
• Left Lane Capital